Accessioner
BillionToOne · Menlo Park, CAJune 2026–present
My role begins when a clinical specimen reaches the laboratory. I compare the specimen with its requisition, verify identifiers and labeling, document it in the laboratory information system, and prepare it for the next stage of testing. I also isolate plasma and buffy coat under established SOPs.
That work has taught me to treat traceability as part of the science. A specimen is only useful if every transfer, label, and record remains reliable. In a high-throughput environment, accuracy has to hold even when the pace increases.
I work close enough to laboratory operations and management to see the business behind the bench. Staffing, throughput, workflow design, turnaround time, and quality all affect whether a diagnostics company can scale responsibly.
BillionToOne develops molecular diagnostics for prenatal screening and oncology using molecular counting. Seeing that system from the accessioning side gives me a grounded view of what customers and laboratory teams need from a scientific product.